Wow great work @RaceOncology and team! Surpassed expectations once again.
It would be interesting to know how big the market is for each breast cancer subtype, especially those where bisantrene is effective and doxorubicin and epirubicin aren't.
Ann: Impressive Preclinical Bisantrene Breast Cancer Results, page-6
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.37 |
Change
-0.170(11.1%) |
Mkt cap ! $232.5M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.48 | $1.36 | $632.2K | 451.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 76 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 4136 | 2 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |